Research Article

Investigation of cloning strategies for the recombinant expression of a putative immune modulator TIR domain protein from probiotic Lactobacillus casei 21/1

Volume: 1 Number: 1 June 19, 2020
EN

Investigation of cloning strategies for the recombinant expression of a putative immune modulator TIR domain protein from probiotic Lactobacillus casei 21/1

Abstract

TIR domain proteins have a key role in Toll-Like Receptor (TLR) signalling pathway in innate immunity. Bacteria can produce TIR domain proteins and those from pathogens were shown to manipulate TLR signaling via mimicking host proteins. Probiotics can also affect TLR signaling, but the molecular details have not been yet elucidated. In this study, a putative protein from probiotic Lactobacillus casei was identified as a TIR domain protein (LcTIR) based on sequence conservation. Multiple sequence alignments showed that LcTIR has high similarity to known TIR domains and the structural model of LcTIR verified the presence of the TIR domain fold. Following this, the gene encoding LcTIR was cloned in several Escherichia coli plasmids in order to obtain pure protein for structural and biochemical studies. Several fusion partners, promoter systems, different E.coli host strains and induction conditions were investigated to achieve recombinant protein production. In all conditions, recombinant LcTIR was produced at low amounts. The highest amount of protein obtained was GST-LcTIR fusion; in Rosetta(DE3)pLysS cells at 37°C with 0.5mM IPTG induction, where nearly all the protein was found in inclusion bodies. Furthermore, in all the constructs and strains tested, the low amount of LcTIR production suppressed cell growth and this might indicate its potential as an antimicrobial agent which opens a new era on bacterial TIR domains. This study is one of the first studies investigating the presence of probiotic TIR domain proteins, and future studies are needed to obtain soluble protein to assay their effect on TLR signalling mechanisms.

Keywords

Supporting Institution

Scientific and Technical Research Council of Turkey (TÜBİTAK)

Project Number

Project No: 116Z299

Thanks

This research was supported by the Scientific and Technical Research Council of Turkey, TUBITAK (Project No: 116Z299). Authors would like to thank to EMBL for pETM11-SUMO3GFP plasmid and M.Sc.Dicle Dilara Akpınar for technical assistance.

References

  1. Ahmad I, Nawaz N, Darwesh NM, ur Rahman S, Mustafa MZ, Khan SB, Patching SG (2018) Overcoming challenges for amplified expression of recombinant proteins using Escherichia coli. Protein Expression Purif 144:12–18. doi:10.1016/j.pep.2017.11.005
  2. Castillo NA, Perdigán G, De Moreno De Leblanc A (2011) Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol 11(1):177. doi:10.1186/1471-2180-11-177
  3. Chaudhar A, Ganguly K, Cabantous S, Waldo GS, Micheva-Viteva SN, Nag K., Hlavacek WS, Tung CS (2012) The Brucella TIR-like protein TcpB interacts with the death domain of MyD88. Biochem Biophys Res Commun 417(1):299–304. doi:10.1016/j.bbrc.2011.11.104
  4. Chhetri G, Kalita P, Tripathi T (2015) An efficient protocol to enhance recombinant protein expression using ethanol in Escherichia coli. MethodsX 2:385–391. doi:10.1016/j.mex.2015.09.005
  5. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, Svanborg C, Miethke T (2008) Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14(4):399–406. doi.org/10.1038/nm1734
  6. EMBL (2019) Decreasing Protein Toxicity. Available via Dialog. https://www.embl.de/pepcore/pepcore_services/index.html of subordinate document. Accesed 10 June 2019
  7. Galdeano CM, de Moreno de LeBlanc A, Vinderola G, Bonet MEB, Perdigon G (2007) Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol 14(5):485–492. doi.org/10.1128/CVI.00406-06
  8. Hoarau C, Lagaraine C, Martin, L (2006) Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 50:696–702. doi.org/10.1016/j.jaci.2005.10.043

Details

Primary Language

English

Subjects

Engineering

Journal Section

Research Article

Publication Date

June 19, 2020

Submission Date

May 10, 2020

Acceptance Date

June 17, 2020

Published in Issue

Year 2020 Volume: 1 Number: 1

APA
Bakar, B., İçier, S., & Kaplan Türköz, B. (2020). Investigation of cloning strategies for the recombinant expression of a putative immune modulator TIR domain protein from probiotic Lactobacillus casei 21/1. Bulletin of Biotechnology, 1(1), 23-29. https://izlik.org/JA63LW69YE
AMA
1.Bakar B, İçier S, Kaplan Türköz B. Investigation of cloning strategies for the recombinant expression of a putative immune modulator TIR domain protein from probiotic Lactobacillus casei 21/1. Bull. Biotechnol. 2020;1(1):23-29. https://izlik.org/JA63LW69YE
Chicago
Bakar, Bahar, Seyhan İçier, and Burcu Kaplan Türköz. 2020. “Investigation of Cloning Strategies for the Recombinant Expression of a Putative Immune Modulator TIR Domain Protein from Probiotic Lactobacillus Casei 21 1”. Bulletin of Biotechnology 1 (1): 23-29. https://izlik.org/JA63LW69YE.
EndNote
Bakar B, İçier S, Kaplan Türköz B (June 1, 2020) Investigation of cloning strategies for the recombinant expression of a putative immune modulator TIR domain protein from probiotic Lactobacillus casei 21/1. Bulletin of Biotechnology 1 1 23–29.
IEEE
[1]B. Bakar, S. İçier, and B. Kaplan Türköz, “Investigation of cloning strategies for the recombinant expression of a putative immune modulator TIR domain protein from probiotic Lactobacillus casei 21/1”, Bull. Biotechnol., vol. 1, no. 1, pp. 23–29, June 2020, [Online]. Available: https://izlik.org/JA63LW69YE
ISNAD
Bakar, Bahar - İçier, Seyhan - Kaplan Türköz, Burcu. “Investigation of Cloning Strategies for the Recombinant Expression of a Putative Immune Modulator TIR Domain Protein from Probiotic Lactobacillus Casei 21 1”. Bulletin of Biotechnology 1/1 (June 1, 2020): 23-29. https://izlik.org/JA63LW69YE.
JAMA
1.Bakar B, İçier S, Kaplan Türköz B. Investigation of cloning strategies for the recombinant expression of a putative immune modulator TIR domain protein from probiotic Lactobacillus casei 21/1. Bull. Biotechnol. 2020;1:23–29.
MLA
Bakar, Bahar, et al. “Investigation of Cloning Strategies for the Recombinant Expression of a Putative Immune Modulator TIR Domain Protein from Probiotic Lactobacillus Casei 21 1”. Bulletin of Biotechnology, vol. 1, no. 1, June 2020, pp. 23-29, https://izlik.org/JA63LW69YE.
Vancouver
1.Bahar Bakar, Seyhan İçier, Burcu Kaplan Türköz. Investigation of cloning strategies for the recombinant expression of a putative immune modulator TIR domain protein from probiotic Lactobacillus casei 21/1. Bull. Biotechnol. [Internet]. 2020 Jun. 1;1(1):23-9. Available from: https://izlik.org/JA63LW69YE